Le Lézard
Classified in: Covid-19 virus
Subjects: SVY, SCZ

Research Study Shows Seniors Still Interested in Moving to Your Community, But You Better Talk to Them About the Right Things


PHILADELPHIA, Dec. 15, 2020 /PRNewswire/ -- As with nearly every industry, the Senior Living market has been impacted greatly by the COVID-19 pandemic. A recent research study of 250 adults over age 65, conducted by LevLane Inc., and MarketVision Research Inc., provides insight into just what the industry needs to do in order to quell the fears of prospective residents.

The study found that while 64% of those surveyed who had been considering a move to a Senior Living Community pre-COVID, were still interested in moving into a senior living community within the next five years, and of those 17% were very interested. However, that leaves nearly 35% who have been scared off by the pandemic and are now much less interested in the prospect of moving to a community setting.

But there is something the Senior Living industry can do to reassure their audience ? talk to them. In fact, an overwhelming 73% of respondents said that they would be much more likely to move to a community that speaks openly about their COVID-19 protections and prevention methods within their communications, with 70% of respondents saying the following six messages would be important to hear from the community:

  1. The facility is meeting/exceeding state and local guidelines for Senior Living Communities
  2. The facility is meeting/exceeding all CDC requirements for Senior Living Communities
  3. Transparency regarding residents and staff who have tested positive for COVID-19
  4. The stringency of their COVID-19 testing protocols for staff and visitors
  5. Information regarding community requirements for mask use and facial coverings
  6. The ability to safely distance

But messaging around COVID-19 wasn't the only thing respondents found important to bring them back to table ? so did providing stronger guarantees. In fact, 86% said that a "Satisfaction Guarantee" would be important when choosing a senior living community.

To see the findings in their entirety, go to https://go.levlane.com/insightslab-covid-senior-living and download the full infographic.

About LevLane Inc.
LevLane Inc, is a marketing firm based in Philadelphia, PA for over 36 years and has specialized expertise in the senior living and healthcare spaces.

About MarketVision, Inc.
For nearly 40 years MarketVision has provided its clients with innovative design, execution and interpretation of marketing research to deliver fresh consumer insights and market knowledge to clients worldwide.

If you are interested in speaking to our Senior Living team, please contact:
Kelly Sizemore
[email protected] 
913-626-2841

If you are interested in speaking to our Research team, please contact:
David Huehnergarth
[email protected] 
609-203-3695

For all other press or media inquiries, please contact:
Liz Weir
[email protected] 
610-401-4825

SOURCE LevLane Inc.


These press releases may also interest you

at 07:00
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") for violations of 10(b) and 20(a) of the Securities...

at 07:00
YS Biopharma Co., Ltd. ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and...

at 06:40
The Gross Law Firm issues the following notice to shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation . Shareholders who...

at 06:00
The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...



News published on and distributed by: